Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
RESEARCH TOOLSreports
Holding BMRN?
Track your performance easily
See the Price Targets and Ratings of:
BMRN Analyst Ratings
Moderate Buy
20 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
BMRN Stock 12 Month Forecast
Average Price Target
$98.52
▲(57.48% Upside)
| Highest Price Target$139.00 | Average Price Target$98.52 | Lowest Price Target$65.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Citi
Reiterated
11/17/24
Wolfe Research
Initiated
11/14/24
Wedbush
Initiated
11/04/24
Barclays
Reiterated
10/31/24
Oppenheimer
Reiterated
10/31/24
Truist Financial
Assigned
10/30/24
Evercore ISI
Assigned
10/30/24
Leerink Partners
Reiterated
10/30/24
Jefferies
Assigned
10/30/24
Bank of America Securities
Reiterated
10/30/24
J.P. Morgan
$109
Buy
74.23%
Upside
Assigned
10/30/24
BioMarin price target lowered to $109 from $110 at JPMorganBioMarin price target lowered to $109 from $110 at JPMorgan
TD Cowen
$120
Buy
91.82%
Upside
Assigned
10/30/24
BioMarin Pharmaceutical's Strong Q3 Performance and Positive 2024 Outlook Reinforce Buy Rating
Stifel Nicolaus
$87→$89
Buy
42.26%
Upside
Reiterated
10/30/24
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (NASDAQ: BMRN), Neurocrine (NASDAQ: NBIX) and Atricure (NASDAQ: ATRC)
Scotiabank
$78
Hold
24.68%
Upside
Reiterated
10/30/24
Scotiabank Remains a Hold on BioMarin Pharmaceutical (BMRN)
UBS
$104→$106
Buy
69.44%
Upside
Reiterated
10/30/24
BioMarin price target raised to $106 from $104 at UBSBioMarin price target raised to $106 from $104 at UBS
Best Analysts Covering BioMarin Pharmaceutical
Which Analyst Should I Follow If I Want to Buy BMRN and Sell After:
1 Month
xxx
Success Rate
20/37 ratings generated profit
Average Return
+1.28%
assigned a xxx
rating 29 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.05% of your transactions generating a profit, with an average return of +1.28% per trade.
3 Months
xxx
Success Rate
10/23 ratings generated profit
Average Return
+0.70%
reiterated a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 43.48% of your transactions generating a profit, with an average return of +0.70% per trade.
1 Year
Success Rate
23/47 ratings generated profit
Average Return
-2.14%
assigned a buy rating 22 days ago
Copying Cory Kasimov's trades and holding each position for 1 Year would result in 48.94% of your transactions generating a profit, with an average return of -2.14% per trade.
2 Years
xxx
Success Rate
10/22 ratings generated profit
Average Return
-5.60%
assigned a xxx
rating 22 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 45.45% of your transactions generating a profit, with an average return of -5.60% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
BMRN Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
2
5
9
19
16
Buy
12
24
38
44
29
Hold
6
10
16
23
18
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
39
63
86
63
Each month's total comprises the sum of three months' worth of ratings.
BMRN Financial Forecast
BMRN Stock Forecast FAQ
What is BMRN’s average 12-month price target, according to analysts?
Based on analyst ratings, BioMarin Pharmaceutical’s 12-month average price target is $98.52.
What is BMRN’s upside potential, based on the analysts’ average price target?
BioMarin Pharmaceutical has 57.48% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is BMRN a Buy, Sell or Hold?
BioMarin Pharmaceutical has a consensus rating of Moderate Buy which is based on 20 buy ratings, 7 hold ratings and 0 sell ratings.
What is BioMarin Pharmaceutical’s price target?
The average price target for BioMarin Pharmaceutical is $98.52. This is based on 27 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $139.00 ,the lowest forecast is $65.00. The average price target represents 57.48% Increase from the current price of $62.56.
The highest analyst price target is $139.00 ,the lowest forecast is $65.00. The average price target represents 57.48% Increase from the current price of $62.56.
What do analysts say about BioMarin Pharmaceutical?
BioMarin Pharmaceutical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 27 Wall Streets Analysts.
How can I buy shares of BMRN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.